Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Two-drug eye injection combo aims to cut treatment visits in half for vision condition

NCT ID NCT01295112

Summary

This study tested whether adding an Ozurdex implant to standard Avastin eye injections could reduce the total number of injections needed over six months for adults with a type of retinal vein blockage. Researchers wanted to see if this combination approach would help control the condition while requiring fewer treatment visits. The main goal was to count how many additional Avastin injections patients needed during the study period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Texas Retina Associates

    Dallas, Texas, 75231, United States

Conditions

Explore the condition pages connected to this study.